Correlation Between NeuroSense Therapeutics and Alector

Can any of the company-specific risk be diversified away by investing in both NeuroSense Therapeutics and Alector at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NeuroSense Therapeutics and Alector into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NeuroSense Therapeutics Ltd and Alector, you can compare the effects of market volatilities on NeuroSense Therapeutics and Alector and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NeuroSense Therapeutics with a short position of Alector. Check out your portfolio center. Please also check ongoing floating volatility patterns of NeuroSense Therapeutics and Alector.

Diversification Opportunities for NeuroSense Therapeutics and Alector

-0.77

Correlation Coefficient

NeuroSense Therapeutics  Alector

Pay attention - limited upside

The 3 months correlation between NeuroSense and Alector is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding NeuroSense Therapeutics Ltd and Alector in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alector and NeuroSense Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NeuroSense Therapeutics Ltd are associated (or correlated) with Alector. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alector has no effect on the direction of NeuroSense Therapeutics i.e., NeuroSense Therapeutics and Alector go up and down completely randomly.

Pair Corralation between NeuroSense Therapeutics and Alector

Assuming the 90 days horizon NeuroSense Therapeutics Ltd is expected to generate 18.88 times more return on investment than Alector. However, NeuroSense Therapeutics is 18.88 times more volatile than Alector. It trades about 0.1 of its potential returns per unit of risk. Alector is currently generating about -0.03 per unit of risk. If you would invest  24.00  in NeuroSense Therapeutics Ltd on October 7, 2024 and sell it today you would earn a total of  12.00  from holding NeuroSense Therapeutics Ltd or generate 50.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	73.79%
Values	Daily Returns

NeuroSense Therapeutics Ltd  vs.  Alector

NeuroSense Therapeutics

Risk-Adjusted Performance

18 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 18 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Alector

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Alector has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in February 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with NeuroSense Therapeutics and Alector

The main advantage of trading using opposite NeuroSense Therapeutics and Alector positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NeuroSense Therapeutics position performs unexpectedly, Alector can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alector will offset losses from the drop in Alector's long position.

The idea behind NeuroSense Therapeutics Ltd and Alector pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.